168 related articles for article (PubMed ID: 23067100)
1. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.
Hsu CW; Chang YJ; Chang CH; Chen LC; Lan KL; Ting G; Lee TW
Cancer Biother Radiopharm; 2012 Oct; 27(8):481-9. PubMed ID: 23067100
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.
Tsai CC; Chang CH; Chen LC; Chang YJ; Lan KL; Wu YH; Hsu CW; Liu IH; Ho CL; Lee WC; Ni HC; Chang TJ; Ting G; Lee TW
Int J Nanomedicine; 2011; 6():2607-19. PubMed ID: 22114492
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model.
Chen LC; Wu YH; Liu IH; Ho CL; Lee WC; Chang CH; Lan KL; Ting G; Lee TW; Shien JH
Nucl Med Biol; 2012 Jan; 39(1):35-43. PubMed ID: 21958858
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model.
Chang YJ; Chang CH; Yu CY; Chang TJ; Chen LC; Chen MH; Lee TW; Ting G
Nucl Med Biol; 2010 Jan; 37(1):95-104. PubMed ID: 20122674
[TBL] [Abstract][Full Text] [Related]
5. MicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing mice.
Chen MH; Chang CH; Chang YJ; Chen LC; Yu CY; Wu YH; Lee WC; Yeh CH; Lin FH; Lee TW; Yang CS; Ting G
Anticancer Res; 2010 Jan; 30(1):65-72. PubMed ID: 20150618
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-bMEDA-liposome in a C26 murine colon carcinoma solid tumor animal model.
Chang YJ; Chang CH; Chang TJ; Yu CY; Chen LC; Jan ML; Luo TY; Lee TW; Ting G
Anticancer Res; 2007; 27(4B):2217-25. PubMed ID: 17695506
[TBL] [Abstract][Full Text] [Related]
7. Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy.
Chang CH; Stabin MG; Chang YJ; Chen LC; Chen MH; Chang TJ; Lee TW; Ting G
Cancer Biother Radiopharm; 2008 Dec; 23(6):749-58. PubMed ID: 19111045
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging and therapeutic efficacy of 188Re-(DXR)-liposome-BBN in AR42J pancreatic tumor-bearing mice.
Chang YJ; Yu CY; Hsu CW; Lee WC; Chen SJ; Chang CH; Lee TW
Oncol Rep; 2012 Nov; 28(5):1736-42. PubMed ID: 22922965
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of (188)Re-DXR-liposome in C26 colon carcinoma ascites mice model.
Chen LC; Chang CH; Yu CY; Chang YJ; Wu YH; Lee WC; Yeh CH; Lee TW; Ting G
Nucl Med Biol; 2008 Nov; 35(8):883-93. PubMed ID: 19026950
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model.
Lin LT; Chang CH; Yu HL; Liu RS; Wang HE; Chiu SJ; Chen FD; Lee TW; Lee YJ
J Nucl Med; 2014 Nov; 55(11):1864-70. PubMed ID: 25349220
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of 188Re-liposome in a C26 murine colon carcinoma solid tumor model.
Chang YJ; Hsu CW; Chang CH; Lan KL; Ting G; Lee TW
Invest New Drugs; 2013 Aug; 31(4):801-11. PubMed ID: 23224353
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution, pharmacokinetics and imaging of (188)Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model.
Chen LC; Chang CH; Yu CY; Chang YJ; Hsu WC; Ho CL; Yeh CH; Luo TY; Lee TW; Ting G
Nucl Med Biol; 2007 May; 34(4):415-23. PubMed ID: 17499731
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.
Huang FY; Lee TW; Chang CH; Chen LC; Hsu WH; Chang CW; Lo JM
Int J Nanomedicine; 2015; 10():463-73. PubMed ID: 25624760
[TBL] [Abstract][Full Text] [Related]
14. External beam radiotherapy synergizes ¹⁸⁸Re-liposome against human esophageal cancer xenograft and modulates ¹⁸⁸Re-liposome pharmacokinetics.
Chang CH; Liu SY; Chi CW; Yu HL; Chang TJ; Tsai TH; Lee TW; Chen YJ
Int J Nanomedicine; 2015; 10():3641-9. PubMed ID: 26056445
[TBL] [Abstract][Full Text] [Related]
15. Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model.
Lin LT; Chang CY; Chang CH; Wang HE; Chiou SH; Liu RS; Lee TW; Lee YJ
Oncotarget; 2016 Oct; 7(40):65782-65796. PubMed ID: 27588466
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D
Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models.
Lin YY; Chang CH; Li JJ; Stabin MG; Chang YJ; Chen LC; Lin MH; Tseng YL; Lin WJ; Lee TW; Ting G; Chang CA; Chen FD; Wang HE
Cancer Biother Radiopharm; 2011 Jun; 26(3):373-80. PubMed ID: 21711113
[TBL] [Abstract][Full Text] [Related]
19. Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer.
Neijzen R; Wong MQ; Gill N; Wang H; Karim T; Anantha M; Strutt D; Waterhouse D; Bally MB; Tai IT; Ng SS; Yapp DT
J Control Release; 2015 Feb; 199():72-83. PubMed ID: 25497312
[TBL] [Abstract][Full Text] [Related]
20. Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response.
Soundararajan A; Bao A; Phillips WT; McManus LM; Goins BA
Cancer Biother Radiopharm; 2011 Oct; 26(5):603-14. PubMed ID: 21834653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
